GILEAD SCIENCES, INC.

Business Segments Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 20:00:00 13/03/2026 GMT			5-day change	1st Jan Change
144.99 ^USD	+0.42%		+0.74%	+18.13%

03-11	Gilead Sciences, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:00 AM
03-10	Gilead Sciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 11:20 AM

Sales 2025 by Business Segment

© MarketScreener.com See more

Sales 2025 by Geography

© MarketScreener.com See more

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Biological Products
Discovery, Development and Commercialization of Innovative Medicines						27.3B	27.28B	27.12B	28.75B	29.44B
Total Assets						67.95B	63.17B	62.12B	59B	59.02B
Interest Expense						-1B	-935M	-944M	-977M	-1.02B
Income Tax Expense						2.08B	1.25B	1.25B	211M	1.29B
CAPEX						-579M	-728M	-585M	-523M	-563M
EBT						8.28B	5.81B	6.86B	690M	9.8B
D&A						2.05B	2.1B	2.69B	2.77B	2.76B
Operating Income						9.92B	7.33B	7.6B	1.66B	10.02B
Net Income						6.22B	4.59B	5.66B	480M	8.51B

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
United States						19.27B	18.88B	19.44B	20.59B	20.88B
Total Assets						4.1B	4.5B	4.69B	4.79B	4.98B
Europe						4.87B	4.47B	4.31B	4.63B	5.06B
Rest of World						3.16B	3.93B	3.37B	3.53B	3.5B
Total Assets						963M	973M	626M	627M	631M
Japan						-	-	-	-	-

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!

BENEFIT NOW